Acumen Pharmaceuticals (ABOS) EPS (Basic) (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted EPS (Basic) of -$0.33 for Q1 2026, up 17.65% sequentially from -$0.41 in Q4 2025, and up 29.97% YoY from -$0.26 in Q1 2025.
Acumen Pharmaceuticals (ABOS) EPS (Basic) (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported EPS (Basic) for 7 years, with the latest figure at -$0.33 in Q1 2026.
- Quarterly EPS (Basic) rose 29.97% year-over-year to -$0.33 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.78 (up 9.28% YoY) and the FY2025 annual result came in at -$3.33, down 28.14% from the prior year.
- EPS (Basic) climbed to -$0.33 in Q1 2026 per ABOS's latest filing, from -$0.41 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.23 in Q1 2022 and troughed at -$1.26 in Q3 2022.
- A 5-year average of -$0.45 and a median of -$0.36 in 2024 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 99.56% in 2022, down 1133.43% in 2022.
- Over 5 years, EPS (Basic) stood at -$0.35 in 2022, then grew by 13.1% to -$0.3 in 2023, then sank by 111.67% to -$0.64 in 2024, then surged by 36.54% to -$0.41 in 2025, then gained by 17.65% to -$0.33 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.33, -$0.41, and -$0.43 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Acumen Pharmaceuticals | 229.03 Mn | 229.03 Mn | - | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.51 |
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.41 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -0.67 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -0.50 |
| Jun 30, 2024 | -0.36 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.35 |
| Sep 30, 2022 | -1.26 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.42 |
| Sep 30, 2021 | -0.10 |